查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1514975

磺胺市場，按給藥途徑、應用、最終用戶、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Sulphonamides Market, By Route of Administration, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 263 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023年磺胺類藥物市場規模為1.294億美元，2024年至2032年複合年成長率為4.50%。

磺胺類藥物市場-市場動態

感染、慢性病的盛行率不斷上升以及對組合療法的高需求預計將推動市場需求

隨著傳染病持續對全球健康構成重大挑戰，對磺胺類藥物等有效抗生素的需求正在大幅增加。泌尿道感染、呼吸道感染和性傳染病等細菌感染的增加推動了對包括磺胺類藥物在內的抗生素的需求。磺胺類藥物也用於治療慢性疾病，例如類風濕性關節炎（例如柳氮磺胺吡啶）和發炎性腸道疾病。這些疾病的流行推動了對含有磺胺成分的藥物的持續需求。

磺胺類藥物通常與其他抗生素（如甲氧芐啶，例如複方新諾明）合併使用，以增強療效並對抗抗藥性。此類聯合療法的開發和使用有助於增加臨床實踐中對磺胺類藥物的需求。與新型抗生素相比，磺胺類藥物更便宜。這種成本效益在資源有限的醫療系統中尤其重要，這些抗生素仍可提供有效的治療選擇。預計這些因素將促進市場成長。

磺胺類藥物市場 - 主要見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 4.50% 左右的複合年成長率成長

根據給藥途徑細分，由於最近的 COVID-19 危機和治療，預計口服細分市場將在 2023 年顯示最大的市場佔有率。

根據應用細分，泌尿道感染 (UTI) 領域是 2023 年的主要應用，因為細菌感染的增加也會導致死亡率。

根據最終用戶細分，由於泌尿、糖尿病和其他慢性疾病的治療有很高的需求，醫院細分市場將在 2023 年成為領先的最終用戶。

按地區分類，由於慢性病盛行率較高，北美將成為 2023 年的主要收入來源。

磺胺類藥物市場-細分分析：

全球磺胺類藥物市場根據給藥途徑、應用、最終用戶和地區進行細分。

根據給藥途徑，市場分為三類：口服、外用和其他。口腔細分市場佔據主導地位。對抗生素和傳染病治療的高需求正在補充市場的成長。

根據應用，市場分為五類：皮膚感染、泌尿道感染（UTI）、呼吸道感染（RTI）、胃腸道（GIT）等。基於 PCR 的方法細分市場佔據主導地位。泌尿相關疾病的增加和尿路感染的新研究正在推動細分市場的需求。

根據最終用戶，市場分為三類：醫院、診所和其他。醫院領域在市場中佔據主導地位，預計在預測期內將保持其高度主導地位。皮膚和腎臟傳播疾病的技術和治療的進步主要推動了市場的成長。

磺胺類藥物市場 - 地理洞察

在全球範圍內，磺胺類藥物市場廣泛分佈於北美、拉丁美洲、歐洲、亞太地區、中東和非洲地區。醫療體系健全的已開發地區，如北美、西歐以及日本、澳洲等亞太地區部分地區，磺胺類藥物的消費量往往較高。這是由於更容易獲得醫療保健設施。拉丁美洲、東歐、亞太地區（例如印度、中國）和非洲國家正在經歷醫療保健支出的增加和醫療保健基礎設施的改善。

磺胺類藥物市場-競爭格局：

磺胺類藥物市場競爭中等。公司根據當地市場條件、監管環境和醫療保健系統調整策略。老牌企業通常擁有全球業務，分銷網路遍佈多個國家。製造程序和技術的進步在競爭定位中發揮重要作用。採用和整合新技術進行生產或配方增強的公司可以提高效率和產品品質。此外，競爭公司在研發方面投入巨資，以開發新配方、提高療效並減少磺胺類藥物的副作用。這項持續的研究推動了市場的創新和差異化。

最近的發展：

2022年8月，法雷奧製藥公司與加拿大諾華製藥公司就SIMBRINZA的商業化達成了供應和商業化協議。

2022年7月，Azurity Pharmaceuticals Inc.獲得美國FDA對ZONISADE的認可。

目錄

第 1 章：磺胺類藥物市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 依給藥途徑分類的磺胺類市場片段
    • 磺胺類藥物市場片段（依應用）
    • 最終用戶的磺胺市場片段
    • 按國家/地區分類的磺胺類市場片段
    • 按地區分類的磺胺類市場片段
  • 競爭洞察

第 3 章：磺胺類藥物主要市場趨勢

  • 磺胺類藥物市場促進因素
    • 市場促進因素的影響分析
  • 磺胺類藥物市場限制
    • 市場限制影響分析
  • 磺胺類藥物市場機會
  • 磺胺類藥物市場未來趨勢

第 4 章：磺胺類藥物產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：磺胺類市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：磺胺類藥物市場格局

  • 2024 年磺胺類藥物市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：磺胺類藥物市場 - 按給藥途徑

  • 概述
    • 按給藥途徑分類的細分市場佔有率分析
    • 口服
    • 專題
    • 其他

第 8 章：磺胺類藥物市場 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 皮膚感染
    • 泌尿道感染（UTI）
    • 呼吸道感染 (RTI)
    • 胃腸道 (GIT)
    • 其他

第 9 章：磺胺類市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 醫院
    • 診所
    • 其他

第 10 章：磺胺類藥物市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美磺胺類主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模與預測（按管理途徑）
    • 北美市場規模和預測（按應用）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲磺胺類主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按管理途徑）
    • 歐洲市場規模和預測（按應用）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區磺胺類主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（依管理途徑）
    • 亞太地區市場規模與預測（按應用）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲磺胺類主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按管理途徑）
    • 拉丁美洲市場規模與預測（按應用）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲磺胺類主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按管理途徑）
    • 中東和非洲市場規模及預測（按應用）
    • 中東和非洲市場規模和預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 磺胺類藥物產業

  • 競爭儀表板
  • 公司簡介
    • Pfizer Inc.
    • GlaxoSmithKline plc
    • Novartis AG
    • Sanofi SA
    • F. Hoffmann-La Roche Ltd
    • Merck & Co., Inc.
    • Bayer AG
    • Johnson & Johnson
    • Abbott Laboratories
    • AstraZeneca PLC
    • Teva Pharmaceutical Industries Ltd.
    • Bristol-Myers Squibb Company
    • Valeo Pharma Inc.
    • Eli Lilly and Company
    • Boehringer Ingelheim International GmbH
    • Mylan NV
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV3081

REPORT HIGHLIGHT

Sulphonamides Market size was valued at USD 129.40 Million in 2023, expanding at a CAGR of 4.50% from 2024 to 2032.

Sulphonamides, also known as sulfonamides, are a class of synthetic antimicrobial agents that work by inhibiting bacterial growth. Sulphonamides is used to treat a range of infections, including urinary tract infections, respiratory tract infections, bacterial meningitis, and some sexually transmitted infections. They are also sometimes used in combination with other antibiotics for synergistic effects.

Sulphonamides Market- Market Dynamics

Growing prevalence of infection, chronic diseases and high demand for combinational therapies are expected to propel market demand

As infectious diseases continue to pose significant global health challenges, the demand for effective antibiotics like sulphonamides is rising significantly. The rise in bacterial infections such as urinary tract infections, respiratory infections, and sexually transmitted diseases drives the need for antibiotics, including sulphonamides. Sulphonamides are also used in the treatment of chronic conditions such as rheumatoid arthritis (e.g., sulfasalazine) and inflammatory bowel disease. The prevalence of these conditions drives ongoing demand for medications containing sulphonamide components.

Sulphonamides are often used in combination with other antibiotics like trimethoprim e.g., co-trimoxazole to enhance efficacy and combat resistance. The development and use of such combination therapies contribute to the demand for sulphonamides in clinical practice. Sulphonamides are more affordable compared to newer antibiotics. This cost-effectiveness is particularly important in healthcare systems with limited resources, where these antibiotics can still provide effective treatment options. These factors are expected to bolster market growth.

Sulphonamides Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.50% over the forecast period (2024-2032)

Based on Route of Administration segmentation, the oral segment was predicted to show maximum market share in the year 2023, owing to the recent COVID-19 crisis & cure.

Based on Application segmentation, the urinary tract infection (UTI) segment was the leading Application in 2023, owing to rising bacterial infection that causes mortality also.

Based on End User segmentation, the hospital segment was the leading End User in 2023, owing to the high need for treatment of urinary, diabetic, and other chronic disorders.

On the basis of region, North America was the leading revenue generator in 2023, owing to high prevalence of chronic diseases.

Sulphonamides Market- Segmentation Analysis:

The Global Sulphonamides Market is segmented on the basis of Route of Administration, Application, End User, and Region.

The market is divided into three categories based on the Route of Administration: oral, topical, and others. The oral segment dominates the market. The high demand for antibiotics and infectious disease treatment is supplementing the market growth.

The market is divided into five categories based on the Application: skin infection, urinary tract infection (UTI), respiratory tract infection (RTI), gastrointestinal tract (GIT), and others. The PCR-based method segment dominates the market. Rising urinary-related diseases and new research in UTIs is contributing to segment demand.

The market is divided into three categories based on End Users: hospitals, clinics, and others. The hospital segment dominates the market and is expected to maintain its high dominance during the forecast period. The advancement in technologies and treatment of skin, and kidney transmitted disorders are mainly boosting the market growth.

Sulphonamides Market- Geographical Insights

Worldwide, the Sulphonamides market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Developed regions with robust healthcare systems, such as North America, Western Europe, and parts of Asia-Pacific including Japan, Australia, etc. often have higher consumption of sulphonamides. This is due to better access to healthcare facilities. Countries in Latin America, Eastern Europe, Asia-Pacific (e.g., India, China), and Africa are experiencing increasing healthcare expenditure and improving healthcare infrastructure.

Sulphonamides Market- Competitive Landscape:

The Sulphonamides market is moderately competitive. Companies adapt their strategies to local market conditions, regulatory environments, and healthcare systems. Established players often have a global presence with distribution networks spanning multiple countries. Advances in manufacturing processes and technologies play a significant role in competitive positioning. Companies that adopt and integrate new technologies for production or formulation enhancement can improve efficiency and product quality. Further, competing companies invest heavily in R&D to develop new formulations, improve efficacy, and reduce the side effects of sulphonamide drugs. This ongoing research drives innovation and differentiation in the market.

Recent Developments:

In August 2022, Valeo Pharma Inc. formed a supply and commercialization agreement with Novartis Pharmaceuticals in Canada for the commercialization of SIMBRINZA.

In July 2022, Azurity Pharmaceuticals Inc. established endorsement from the US FDA for ZONISADE.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SULPHONAMIDES MARKET KEY PLAYERS

  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Novartis AG
  • Sanofi S.A.
  • F. Hoffmann-La Roche Ltd
  • Merck & Co., Inc.
  • Bayer AG
  • Johnson & Johnson
  • Abbott Laboratories
  • AstraZeneca PLC
  • Teva Pharmaceutical Industries Ltd.
  • Bristol-Myers Squibb Company
  • Valeo Pharma Inc.
  • Eli Lilly and Company
  • Boehringer Ingelheim International GmbH
  • Mylan N.V.
  • Others

GLOBAL SULPHONAMIDES MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019-2032

  • Oral
  • Topical
  • Others

GLOBAL SULPHONAMIDES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

  • Skin infection
  • Urinary Tract Infection (UTI)
  • Respiratory Tract Infection (RTI)
  • Gastro-Intestinal Tract (GIT)
  • Others

GLOBAL SULPHONAMIDES MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Hospitals
  • Clinics
  • Others

GLOBAL SULPHONAMIDES MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Sulphonamides Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Sulphonamides Market Snippet by Route of Administration
    • 2.1.2. Sulphonamides Market Snippet by Application
    • 2.1.3. Sulphonamides Market Snippet by End User
    • 2.1.4. Sulphonamides Market Snippet by Country
    • 2.1.5. Sulphonamides Market Snippet by Region
  • 2.2. Competitive Insights

3. Sulphonamides Key Market Trends

  • 3.1. Sulphonamides Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Sulphonamides Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Sulphonamides Market Opportunities
  • 3.4. Sulphonamides Market Future Trends

4. Sulphonamides Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Sulphonamides Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Sulphonamides Market Landscape

  • 6.1. Sulphonamides Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Sulphonamides Market - By Route of Administration

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Route of Administration, 2024 & 2032 (%)
    • 7.1.2. Oral
    • 7.1.3. Topical
    • 7.1.4. Others

8. Sulphonamides Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Skin infection
    • 8.1.3. Urinary Tract Infection (UTI)
    • 8.1.4. Respiratory Tract Infection (RTI)
    • 8.1.5. Gastro-Intestinal Tract (GIT)
    • 8.1.6. Others

9. Sulphonamides Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Clinics
    • 9.1.4. Others

10. Sulphonamides Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Sulphonamides Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Sulphonamides Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Sulphonamides Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Sulphonamides Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Sulphonamides Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Sulphonamides Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Pfizer Inc.
    • 11.2.2. GlaxoSmithKline plc
    • 11.2.3. Novartis AG
    • 11.2.4. Sanofi S.A.
    • 11.2.5. F. Hoffmann-La Roche Ltd
    • 11.2.6. Merck & Co., Inc.
    • 11.2.7. Bayer AG
    • 11.2.8. Johnson & Johnson
    • 11.2.9. Abbott Laboratories
    • 11.2.10. AstraZeneca PLC
    • 11.2.11. Teva Pharmaceutical Industries Ltd.
    • 11.2.12. Bristol-Myers Squibb Company
    • 11.2.13. Valeo Pharma Inc.
    • 11.2.14. Eli Lilly and Company
    • 11.2.15. Boehringer Ingelheim International GmbH
    • 11.2.16. Mylan N.V.
    • 11.2.17. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Sulphonamides Market: Route of Administration Snapshot (2024)
  • TABLE Segment Dashboard; Definition and Scope, by Route of Administration
  • TABLE Global Sulphonamides Market, by Route of Administration 2019-2032 (USD Million)
  • TABLE Sulphonamides Market: Application Snapshot (2024)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Sulphonamides Market, by Application 2019-2032 (USD Million)
  • TABLE Sulphonamides Market: End User Snapshot (2024)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Sulphonamides Market, by End User 2019-2032 (USD Million)
  • TABLE Sulphonamides Market: Regional snapshot (2024)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Sulphonamides Market, by Region 2019-2032 (USD Million)
  • TABLE North America Sulphonamides Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Sulphonamides Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE North America Sulphonamides Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Sulphonamides Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Sulphonamides Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Sulphonamides Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE Europe Sulphonamides Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Sulphonamides Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Sulphonamides Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Sulphonamides Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE Asia Pacific Sulphonamides Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Sulphonamides Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Sulphonamides Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Sulphonamides Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE Latin America Sulphonamides Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Sulphonamides Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Sulphonamides Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Sulphonamides Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Sulphonamides Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Sulphonamides Market, by End User, 2019-2032 (USD Million)

List of Figures

  • FIGURE Sulphonamides Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2024
  • FIGURE Route of Administration segment market share analysis, 2024 & 2032
  • FIGURE Route of Administration segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Application segment market share analysis, 2024 & 2032
  • FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE End User segment market share analysis, 2024 & 2032
  • FIGURE End User segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2024 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Sulphonamides Market share and leading players, 2024
  • FIGURE Europe Sulphonamides Market share and leading players, 2024
  • FIGURE Asia Pacific Sulphonamides Market share and leading players, 2024
  • FIGURE Latin America Sulphonamides Market share and leading players, 2024
  • FIGURE Middle East and Africa Sulphonamides Market share and leading players, 2024
  • FIGURE North America market share analysis by country, 2024
  • FIGURE U.S. Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Sulphonamides Market share analysis by country, 2024
  • FIGURE Germany Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Sulphonamides Market share analysis by country, 2024
  • FIGURE India Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philipines Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Sulphonamides Market share analysis by country, 2024
  • FIGURE Brazil Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Sulphonamides Market share analysis by country, 2024
  • FIGURE Saudi Arabia Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)